Polyaromatic ethylene beta-diketone compound or pharmaceutically acceptable salt thereof and application of polyaromatic ethylene beta-diketone compound or pharmaceutically acceptable salt thereof
A technology of polyarylethylene and compounds, applied in organic chemistry, antineoplastic drugs, drug combinations, etc., can solve problems such as no breakthroughs, achieve the effects of inhibiting the repair process, improving the effect of radiotherapy, and improving the effect of radiotherapy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0076] Example β- more than one vinyl aromatic diketones PT33-F, PT33-Cl, PT33-I, PTDO-F, PTDO-Cl, PTDO-Br, Synthesis and characterization of PTDO-I
[0077] Polyaromatic vinyl β- diketones PT33-F, PT33-Cl, PT33-I, PTDO-F, synthetic PTDO-Cl, PTDO-Br, PTDO-I is performed according to the following reaction scheme:
[0078]
[0079] Specifically: in 100mL round-bottomed flask, boron anhydride (0.35g, 5mmol, 1.0eq), acetylacetone (1g, 10mmoL, 2eq) was dissolved in 10mL of ethyl acetate, 70 deg.] C reaction 3h. The solvent was removed by suction filtration, washed twice with cyclohexane, as a white solid. In 100mL round-bottomed flask, as a white solid, corresponding aromatic aldehyde I (20mmoL, 4eq), butyl borate (4.60g, 20mmol, 4.0eq) was dissolved in 20mL ethyl acetate and stirred for 30min 70 ℃. N-butylamine (73mg, 1mmol, 0.2eq) was diluted with 5mL of ethyl acetate, a dropping funnel was added dropwise to the reaction mixture was slowly heated to 85 ℃, the reaction was continue...
Embodiment 2
[0088] Example 2 Formula (1) compound radiotherapy representative tumor cell sensitizing activity shown
[0089] Selecting a representative tumor cell lines of each system, reproductive system tumors include ① containing cervical carcinoma (SW756), endometrial carcinoma (ESS-1), ovarian cancer (OVCAR-5) and prostate (PC-3) cell line; ② tumors including gastric digestive system (AGS), liver cancer (Huh-7), in colorectal cancer (HCTl 16) and pancreatic cancer (PANC1) cell line; ③ nasopharyngeal tumors, including respiratory system (CNE2), hypopharynx (FaDu) and lung cancer (of A549) cell lines; ④ nervous system tumors include astrocytomas (U87), neuroblastoma (ACN) and medulloblastoma (PFSK-1) cell line; ⑤ urinary system tumors including renal cell carcinoma (A704) and bladder cancer (T24) cell line; ⑥ skin cancers include squamous cell carcinoma (of A431), and melanoma (COLO-829) cell line; ⑦ bone and soft tissue sarcomas include osteosarcoma (U20S), and soft tissue sarcomas (HT -1...
Embodiment 3
[0094] Example 3PT33 cell sensitizing activity in different tumor models embodiment
[0095] Characterization of Effects of drugs combined with radiation therapy and colony formation on plates using cloning experiments. The HCT116 and SW837 cells at a density of 1000 cells / well were seeded into 6 well plates, respectively, under normoxic and hypoxic state (5v / v% O 2 )nourish. After 24 hours, treated with X-rays and / or different concentrations of the drug dose specified cells, and then cultured for 10-14 days, then fixed with methanol, stained with crystal violet 0.5%. Collection of cells containing 50 or more colonies were counted, the sensitizer compound with the ability to reduce the front with a multiple cloning cell FC represents, as a result figure 1 Indicated.
[0096] figure 1 The results showed that, PT33 is effective in enhancing the effect of radiotherapy of various tumor cell lines, and under hypoxic conditions, which is further enhanced sensitizing activity.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com